Potential New Targets Identified for Treatment of Acute Kidney Injury
Basic and clinical investigations have identified a role for kidney-derived glycerol-3-phosphate in stimulating circulating fibroblast growth factor 23 after acute kidney injury.
Safe Care CommitmentGet the care you need even during COVID-19.Learn more
Eugene Rhee is Chief of the Nephrology Division at the Massachusetts General Hospital (MGH), a Principal Investigator in the Nephrology Division and Endocrine Unit at the MGH, and an Associate Professor of Medicine at Harvard Medical School. He graduated from Brown University and the University of Pennsylvania School of Medicine and completed his training in Internal Medicine and Nephrology at the MGH. His laboratory studies kidney metabolism using epidemiologic, physiologic, and experimental approaches, with the goal to identify novel markers and mediators of kidney disease and its complications. Dr. Rhee sees general nephrology patients in Renal Associates and attends on the inpatient nephrology consult, ICU, and dialysis services. He lives with his wife and two daughters in Newton, MA.
Clinical Interests:
Treats:
Renal Associates
165 Cambridge Street
Suite 302
Boston, MA 02114-2752
Phone: 617-726-5050
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
In a COVID-19 virtual seminar, experts from Mass General discuss the future of specialized patient care.
Mass General is the #1 Research Hospital in America and the only hospital to be recognized in all 16 specialties assessed by U.S. News & World Report.
Basic and clinical investigations have identified a role for kidney-derived glycerol-3-phosphate in stimulating circulating fibroblast growth factor 23 after acute kidney injury.